Showing results (1-10 of 726) with videos related to
Sort By:
Pageof 73
Revue Medicale De Liege|March 22, 2003
[Clinical study of the month. Which initial antihypertensive? Results from the ALLHAT trial]A J Scheen, J M KrzesinskiRevue Medicale De Liege|January 26, 2008
[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge]J M Krzesinski, A J ScheenRevue Medicale De Liege|December 12, 2007
[Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes]A J Scheen, J M KrzesinskiRevue Medicale De Liege|May 19, 2017
[Importance of stopping some medications in case of gastrointestinal disturbances leading to dehydration]J-M Krzesinski, A J ScheenRevue Medicale De Liege|December 2, 2009
[Sevikar or Forzaten: olmesartan medoxomil and amlodipine besylate fixed combination in the treatment of hypertension]J M Krzesinski, A J ScheenRevue Medicale De Liege|April 18, 2009
[Clinical study of the month. The ACCOMPLISH study: challenging the choice of antihypertensive medications in systolic hypertensive patients with high cardiovascular risk]J M Krzesinski, A J ScheenRevue Medicale De Liege|June 12, 2009
[Fixed combination perindopril-amlodipine (Coveram) in the treatment of hypertension and coronary heart disease]A J Scheen, J M KrzesinskiRevue Medicale Suisse|September 20, 2012
[Is there still a place for a dual blockade of the renin-angiotensin system in 2012?]J-M Krzesinski, A J ScheenRevue Medicale De Liege|December 30, 2004
[The drug of the month: Olmesartan medoxomil]J M Krzesinski, A J ScheenRevue Medicale De Liege|June 26, 2008
[ONTARGET: similar protection of telmisartan and ramipril and lack of benefit of combined therapy in patients at high risk for vascular events]A J Scheen, J M KrzesinskiPageof 73